Results 51 to 60 of about 317,103 (246)

Molecular Mechanisms and Key Processes in Interstitial, Hemorrhagic and Radiation Cystitis

Biology, 2022
Cystitis is a bladder disease with a high rate of prevalence in the world population. This report focuses on Interstitial Cystitis (IC), Hemorrhagic Cystitis (HC) and Chronic Radiation Cystitis. These pathologies have different etiologies, but they share
Clément Brossard, Anne-Charlotte Lefranc, Anne-Laure Pouliet, Jean-Marc Simon, Marc Benderitter, Fabien Milliat, Alain Chapel   +6 more
doaj   +1 more source

Impacts of chronic stress on urinary bladder function & recovery through modification of PACAP signaling [PDF]

, 2016
Stress can cause or contribute to bladder dysfunction though specific effects remain unclear. Individuals with interstitial cystitis (IC)/bladder pain syndrome (BPS) experience increased symptom severity with stress, including pain and increased urgency ...
Mathews, Morgan E
core   +1 more source

Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome

BMC Urology, 2020
Background To evaluate the efficacy of submucosal injection of triamcinolone acetonide for the treatment of type II/III interstitial cystitis/bladder pain syndrome.
Tao Jiang, Xiaozhou Zhou, Zhipeng Chen, Tailin Xiong, Jian Fu, Zhengchao Liu, Dishi Yan, Zhansong Zhou, Wenhao Shen   +8 more
doaj   +1 more source

Assessing somatization in urologic chronic pelvic pain syndrome [PDF]

, 2019
BACKGROUND: This study examined the prevalence of somatization disorder in Urological Chronic Pelvic Pain Syndrome (UCPPS) and the utility of two self-report symptom screening tools for assessment of somatization in patients with UCPPS.
Alpers, D H, Hong, B A, Lai, H H, North, C S   +3 more
core   +1 more source

A Review of NIDDK‐Funded Studies of Urological Chronic Pain Conditions

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction This review highlights NIDDK‐funded clinical research studies focused on interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Methods Since 1987, the NIDDK has funded numerous cohort studies, epidemiologic studies, and clinical trials for these conditions.
J. Quentin Clemens
wiley   +1 more source

Editorial: Special Issue “Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)”

Diagnostics, 2022
Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a disabling chronic disease of still unknown origin and complex pathophysiology [...]
Jochen Neuhaus, Andreas Gonsior, Mandy Berndt-Paetz   +2 more
doaj   +1 more source

Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome

International journal of urology, 2019
To examine the correlation among bladder inflammation, angiogenesis, fibrosis and urothelial denudation in biopsied bladder specimens, and O'Leary‐Sant symptom indexes, O'Leary‐Sant problem indexes and visual analog scale pain scores in interstitial ...
A. Furuta, Yasuyuki Suzuki, T. Igarashi, Yusuke Koike, T. Kimura, S. Egawa, N. Yoshimura   +6 more
semanticscholar   +1 more source

Fibromyalgia: A Unifying Neuroendocrinologic Model for Understanding Its Pathophysiology [PDF]

, 2008
Fibromyalgia is believed to affect at least 2% of the population. Despite advances in the scientific understanding of the derangements of central and peripheral pain processing mechanisms in fibromyalgia, no current models of its pathophysiology account ...
Peter Dorsher
core   +1 more source

Chemotherapy-related complications in the kidneys and collecting system: an imaging perspective [PDF]

, 2015
Nephrotoxicity is a common adverse effect of many chemotherapeutic agents. The agents most commonly associated with chemotherapy-associated nephrotoxicity are methotrexate, semustine, streptozocin, mithramycin, and cisplatin.
Goodwin, Scott C., Gulati, Rajesh, Jia, Jemianne Bautista, Lall, Chandana, Lamba, Ramit, Tirkes, Temel   +5 more
core   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source